[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Newman et al., 1978 - Google Patents

cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation

Newman et al., 1978

Document ID
13031324401667787620
Author
Newman D
Colella D
Spainhour Jr C
Brann E
Zabko-Potapovich B
Wardell Jr J
Publication year
Publication venue
Biochemical Pharmacology

External Links

Snippet

A series of compounds drawn from a wide variety of chemical and pharmacologic classes were tested for their ability to act as inhibitors of a guinea pig tracheal cAMP- phosphodiesterase. Active compounds, defined as equal to or more potent than 1, 3 …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Edwards et al. The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization
Suttorp et al. Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
Wessler et al. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters
Stoltz et al. Inhibition of host phenoloxidase activity by parasitoid hymenoptera
SETHI et al. Nicotinamide inhibits cyclic ADP-ribose-mediated calcium signalling in sea urchin eggs
Silver Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase
Chu et al. Potentiation of 5-fluoro-2′-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine
Newman et al. cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation
Nakatsuji et al. Molt-inhibiting hormone-mediated regulation of ecdysteroid synthesis in Y-organs of the crayfish (Procambarus clarkii): involvement of cyclic GMP and cyclic nucleotide phosphodiesterase
Harper et al. Mitotic response of normal and psoriatic keratinocytes in vitro to compounds known to affect intracellular cyclic AMP
Ochs et al. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function
Harris et al. Effect of cyclic nucleotides on activity of cyclic 3′, 5′-adenosine monophosphate phosphodiesterase
Yacobi et al. Comparative Pharmacokinetics of Coumarin Anticoagulants X: Relationship between Distribution, Eli mination, and Anticoagulant Action of Warfarin
Cory et al. Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivatives
Valette et al. Concanavalin A stimulates the rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes
Johnson et al. N6-substituted adenines induce cell elongation irrespective of the intracellular cyclic AMP levels
Bouaziz et al. Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced activation of endothelial cells
EP0817624B1 (en) Inhibitors of metazoan parasite proteases
Yamaguchi et al. Effect of angiotensin II on renin production by rat adrenal glomerulosa cells in culture.
TAYLOR-PAPADIMITRIOU et al. Effect of interferon on some aspects of transformation by polyoma virus
Marone et al. Inhibition of histamine release from human basophils in vitro by calmodulin antagonists
KOHN et al. ON THE MODE OF ACTION OF THE SULFONAMIDES: III. PURINES, AMINO ACIDS, PEPTONES AND PANCREAS AS ANTAGONISTS AND POTENTIATORS OF SULFONAMIDE IN E. COLI
Campbell et al. On the pharmacology and biochemistry of the amine-uptake mechanism in human blood platelets
Anderson et al. Clofazimine-mediated enhancement of reactive oxidant production by human phagocytes as a possible therapeutic mechanism
Khatsenko et al. Role of nitric oxide in the inhibition of cytochrome P450 in the liver of mice infected with Chlamydia trachomatis